Vancomyzer is the first. The pipeline keeps growing.
Each new drug module is built on the same transparent, evidence-based engine that powers Vancomyzer™ — so your pharmacy team learns it once and applies it across the formulary.
Infectious Disease
LiveVancomycin
AUC-guided dosing for adult inpatients. Available today as Vancomyzer™.
Open VancomyzerInfectious Disease
In DevelopmentVoriconazole
Trough-based TDM for invasive fungal infections, with CYP2C19 phenotype awareness.
Aminoglycoside
In DevelopmentTobramycin
AUC- and Cmax-guided dosing for severe gram-negative and Pseudomonas infections, including cystic fibrosis.
Aminoglycoside
PlannedGentamicin
Completes the aminoglycoside class for antimicrobial stewardship workflows.
Transplant
PlannedTacrolimus
Trough-based TDM for solid-organ transplant maintenance immunosuppression.
Oncology
PlannedMethotrexate (high-dose)
Concentration-driven leucovorin rescue and glucarpidase decision support.
Pediatric and neonatal models will follow each adult module after our hospital pilot study completes.
Vote for the next drug
Tell us which drug your pharmacy team needs next. Your input directly shapes our roadmap.